Skip to content
Compounder
← Stocks

Henry Schein Inc

HSICAbove value

Held by 5 superinvestors.

Price$90.38
Holders5
Total value$143.7M

SEC 10-K · fundamentals

Business quality

as of 2025-12-27

Valuation basis: trailing twelve months to 2026-06-27 — latest 10-K plus unaudited 10-Q filings.

Revenue growth
+4.0%
Net margin
3.0%
ROE
12.3%
FCF margin
4.3%
Revenue $10.12B → $13.18B · 6y
What makes a business high quality

Valuation · value band

Above fair value

$31/ sh · growth-anchored intrinsic value
margin of safety
fair value
above fair value
$90
cheaperpricier

Zero-growth floor

$24

Central IV

$31

Optimistic top

$35

Henry Schein Inc (HSIC): Two methods value the business — a conservative owner-earnings DCF and a growth-credited Greenwald estimate, $24–$35 / sh. Today’s price sits above both (price $90 as of 2026-08-26).

The middle figure is the main read. The right end is the optimistic case under the same conservative caps — not an absolute ceiling.

  • Recent earnings are below the multi-year average, so the band uses the lower run-rate.

Revenue growth 0% (history declining, capped at zero) · moat 10 yr · discount 12.6% · Zero-growth downside $24

Price as of 2026-08-26 · yahoo · DGS10 4.6% @ 2026-08-25.

Method & numbers

A conservative intrinsic-value band (zero-growth floor to growth-capped DCF) plus a tangible asset floor — not investment advice, not a buy/sell signal, and not a price target.

Owner-earnings DCF $27.78 – $34.89 · Greenwald $35.35 – $35.35 (neutral $35.35) · zero-growth base $35.35 · reproduction $4.71

Moat Franchise (moat) · terminal value 30% of present value · owner-earnings yield 4% vs 10Y 4.6%.

Graham earnings-power value (normalized NOPAT)$23.89 – $35.35 / sh

Normalized NOPAT = average operating margin over the years shown × latest-year revenue × (1 − normalized tax); then + D&A − maintenance capex (write A). Unlevered (pre-interest, attributable to all capital). Capitalized at the 9–11% rate band (read as a WACC proxy). Enterprise → equity bridge applied: + cash − total debt.

Years: TTM 2026-06-27, 2024, 2023, 2022, 2021

v1 simplifications: Maintenance capex (degraded) deducted in full cash (write A): EPV = (NOPAT + D&A − maintenance capex) / WACC; no tax shield on the capex term. Maintenance-capex methods diverge by 104% (> 50%); estimate is degraded. Share-based compensation is left as a real expense (not added back). Operating margin is below its multi-year average (cyclical/declining): normalized margin capped at the latest year — no peak-margin capitalization (audit #2).

Buffett owner-earnings value$29.91 – $35.33 / sh

Owner earnings = average net income + average D&A − maintenance capex (zero-growth floor; no ΔNWC). Levered (starts from net income, already after interest — an equity-holder stream). Capitalized at the 11.0–13.0% band (9–11% base + 2.0pp leverage premium). No enterprise→equity bridge: the capitalized result is already equity value (subtracting debt would double-count interest).

Years: TTM 2026-06-27, 2024, 2023, 2022, 2021

v1 simplifications: Net income is below its multi-year average (cyclical/declining): normalized owner earnings anchored to the latest year — no peak-earnings capitalization (audit #2). Owner earnings = net income + D&A − maintenance capex (degraded); the working-capital change is excluded (maintenance ΔNWC ≈ 0; growth ΔNWC is carried in growth value, not double-counted). Maintenance-capex methods diverge by 104% (> 50%); estimate is degraded. One-time items are not separately normalized (multi-year averaging smooths them partially). Share-based compensation is left as a real expense (not added back); see the SBC/OE disclosure. Capitalized at the 9–11% base band plus a 2.0pp leverage premium (cost of equity rises with leverage — MM Proposition II). Net debt is about 7.1 years of owner earnings, adding 2.0pp of cost-of-equity risk premium.

Asset floor: Reproduction value = tangible net assets + acquired-intangible reset proxy, ÷ diluted shares; tangible net assets alone are negative for this asset-light franchise (no R&D history to capitalize).

Moat reading: Franchise test compares earnings power (EPV) against reproduction value (tangible net assets + capitalized R&D). EPV well above reproduction value signals a moat; near it, a commodity; below it, value destruction. A directional reading, not a verdict.

Assumes a narrow moat · competitive-advantage period ≈ 10 years.

Growth value: if the moat holds for 10 yr at ROIIC ≈ -51%, $0.00–$0.00 / sh (neutral $0.00). Conservative, not a forecast.

Window TTM 2026-06-27, FY 2024, 2023, 2022, 2021 · discount band 9%11% · normalized tax 21% (Average effective tax rate over 5 year(s), capped at the statutory 21%.) · diluted shares.

Baseline 9%–11%, net debt ≈ 7.1 years of owner earnings → +2.0pp cost-of-equity premium → effective 11.0%–13.0%.

Owner-earnings DCF: growth g₁ 0% (history declining → capped at 0) · OE FY TTM 2026-06-27, 2024, 2023, 2022, 2021 · Discount band: 11.19%–14.05% (DGS10 +4.5% to a 12% strict end, each +2.05pp for leverage premium, as of 2026-08-25). No enterprise→equity bridge: owner earnings already flow to shareholders (post-interest), so no net cash is added and no debt subtracted — matching the engine owner-earnings lamp. Two-method midpoint gap 13%.

Valuation basis: trailing twelve months to 2026-06-27 — latest 10-K plus unaudited 10-Q filings.

What the price is betting

Today's price pencils in about 21.7% a year in owner-earnings for the next few years. Revenue actually grew 4.0% a year.

The market wants it well ahead of its own track record.

Even when the value band is low-confidence: use this to see what the price assumes — not as a cheapness confirmation.

How to read intrinsic value

SEC 13F · holders

Superinvestors Holding This Security

5 holders · $143.7M combined · this quarter +0 opened / -1 exited

This quarter2 added1 trimmed1 exited
Holders 4 → 4 · last 8q
Exited this quarter (1)

SEC 13F · notes

Written summary

Henry Schein Inc (HSIC) is held by 5 of the superinvestors tracked on Compounder, with a combined $143.7M in reported 13F value. The largest position belongs to Richard Pzena, where it makes up 0.2% of the portfolio.

Other notable holders by value include David Einhorn (1.5% of its book), Robert Olstein (1.2% of its book) and Ray Dalio (0.0% of its book).

Over the latest quarter, 0 of the tracked filers opened a new position in HSIC, 2 added to existing ones, 1 trimmed, and 1 sold out entirely.

Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.

How to read a 13F

SEC 13F · co-ownership

Also held by these investors

Investors holding Henry Schein Inc (HSIC) also commonly hold →

See which stocks look cheap against a conservative value band. Browse all valued stocks

Also on

Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14

Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.

Stay Updated

New-quarter 13F moves and valuation updates, to your inbox.